期刊文献+

Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma 被引量:11

Inhibitory effect of adeno-associated virus-mediated gene transfer of human endostatin on hepatocellular carcinoma
在线阅读 下载PDF
导出
摘要 AIM: To investigate the effect of adeno-associated virusmediated gene transfer of human endostatin on the growth of hepatocellular carcinoma (HCC).METHODS: HCC cell line Hep3B was infected with recombinantadeno-associated virus containing human endostatin gene (rAAV2-hEndo). The results of transfection were detected by RT-PCR and SDS-PAGE assay. MTT assay was used to observe the effects of supernatant of transfected cells on ECV304 cell proliferation. An animal model of HCC was established by injecting Hep3B cells subcutaneously into the back of nude mice. Intratumoral injection of rAAV2hEndo, empty virus and phosphate-buffered saline were given sequentially. Serum endostatin was determined byELISA, the inhibitory effect of endostatin on the growth of xenograft was assessed in 3 wk.RESULTS: The results of RT-PCR and SDS-PAGE assay confirmed that rAAV2-hEndo successfully transfected Hep3B cells, and endostatin was secreted from Hep3B cells to medium. The supernatant of transfected cells markedly inhibited the proliferation of ECV304 cells (P<0.01). Intratumoral injection of rAAV2-hEndo (2×1010v.g.) led to a sustained serum endostatin level ofapproximately (86.71±5.19) ng/mL. The tumor volumeand microvessel density were less in rAAV2-hEndo group than in control groups (P<0.01).CONCLUSION: Human endostatin can be stably expressed by adeno-associated virus-mediated gene transfer and effectively inhibit the growth of HCC. AIM: To investigate the effect of adeno-associated virus-mediated gene transfer of human endostatin on the growth of hepatocellular carcinoma (HCC). METHODS: HCC cell line Hep3B was infected with recombinant adeno-associated virus containing human endostatin gene (rAAV2-hEndo). The results of transfection were detected by RT-PCR and SDS-PAGE assay. MTT assay was used to observe the effects of supernatant of transfected cells on ECV304 cell proliferation. An animal model of HCC was established by injecting Hep3B cells subcutaneously into the back of nude mice. Intratumoral injection of rAAV2-hEndo, empty virus and phosphate-buffered saline were given sequentially. Serum endostatin was determined by ELISA, the inhibitory effect of endostatin on the growth of xenograft was assessed in 3 wk. RESULTS: The results of RT-PCR and SDS-PAGE assay confirmed that rAAV2-hEndo successfully transfected Hep3B cells, and endostatin was secreted from Hep3B cells to medium. The supernatant of transfected cells markedly inhibited the proliferation of ECV304 cells (P<0.01). Intratumoral injection of rAAV2-hEndo (2×1010 v.g.) led to a sustained serum endostatin level of approximately (86.71±5.19) ng/mL. The tumor volume and microvessel density were less in rAAV2-hEndo group than in control groups(P<0.01). CONCLUSION: Human endostatin can be stably expressed by adeno-associated virus-mediated gene transfer and effectively inhibit the growth of HCC.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第22期3331-3334,共4页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China, No. 20074031
关键词 ENDOSTATIN GENE Adeno-associated virus Hepatocellular carcinoma 病毒调节转换因子 肝细胞癌 基因表达 细胞增殖 肿瘤细胞
  • 相关文献

参考文献1

二级参考文献36

  • 1Saphir A. Angiogenesis:the unifying concept in cancer? J Natl Cancer Inst 1997;89:1658-1659.
  • 2Oehler MK, Bicknell R. The promise of anti-angiogenic cancer therapy. Br J Cancer 2000;82:749-752.
  • 3Tomanek RJ, Schatteman GC. Angiogenesis: new insights and therapeutic potential, Anat Rec 2000:261:126-135.
  • 4Thompson WD, Li WW, Maragoudakis M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises,and opportunities with novel human therapies.J Pathol 2000;190:330-337.
  • 5Vacca A, Ribatti D, Pellegrino A, Dammacco F. Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects. Ann Ital Med Int 2000;15:7-19.
  • 6Parangi S,O'Reilly M,Christofori G,Holmgren L,Grosfeld,J,Folkman J, Hanahan D. Antiangiogenic therapy of transgenic mice impairs de-novo tumor-growth. Proc Natl Acad Sci USA 1996;93:2002-2007.
  • 7Boehm T, Folkman J, Browder T, O'Reilly MS. Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997;390:404-407.
  • 8Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y,Johnson F, Engleman EG, Nolan GP. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor effiecacy in leukemia and solid tumors in mice. Mol Ther 2001;3:186-196.
  • 9Scappaticci FA, Contreras A, Smith R, Bonhoure L, Lum B,Cao Y, Engleman EG, Nolan GP. Statin-AE: a novel angiostatinendostatin fusion protein with enhanced antiangiogenic and antitumor activity .Angiogenesis.2001;4:263-268.
  • 10Folkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci USA1998;95:9064-9066.

共引文献7

同被引文献37

引证文献11

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部